| # | Drug | Count |
|---|---|---|
| 0 | PEMETREXED DISODIUM | 92 |
| 1 | GEMCITABINE HYDROCHLORIDE | 74 |
| 2 | PEMETREXED | 69 |
| 3 | PEMBROLIZUMAB | 61 |
| 4 | CARBOPLATIN | 56 |
| 5 | GEMCITABINE | 50 |
| 6 | PACLITAXEL | 23 |
| 7 | CYCLOPHOSPHAMIDE | 22 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 22 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PACLITAXEL PROTEIN-BOUND PARTICLES | 1 | 0.1000 |
| 1 | PEMETREXED DISODIUM | 92 | 0.0024 |
| 2 | GEMCITABINE HYDROCHLORIDE | 74 | 0.0014 |
| 3 | CERITINIB | 3 | 0.0013 |
| 4 | ANASTROZOLE TABLETS | 16 | 0.0007 |
| 5 | LORLATINIB | 5 | 0.0007 |
| 6 | ETOPOSIDE PHOSPHATE | 1 | 0.0006 |
| 7 | DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE | 1 | 0.0006 |
| 8 | PEMBROLIZUMAB | 61 | 0.0006 |
| 9 | ANASTROZOLE | 16 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 69 |
| 1 | Platinum-based Drug [EPC] | 64 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 61 |
| 3 | Corticosteroid [EPC] | 39 |
| 4 | Aromatase Inhibitor [EPC] | 25 |
| 5 | Microtubule Inhibitor [EPC] | 24 |
| 6 | Kinase Inhibitor [EPC] | 23 |
| 7 | Alkylating Drug [EPC] | 22 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 19 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 18 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 61 | 0.0006 |
| 1 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 2 | Platinum-based Drug [EPC] | 64 | 0.0002 |
| 3 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 4 | Aromatase Inhibitor [EPC] | 25 | 0.0002 |
| 5 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 1 | 0.0002 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 69 | 0.0002 |
| 7 | Microtubule Inhibitor [EPC] | 24 | 0.0001 |
| 8 | Erythropoiesis-stimulating Agent [EPC] | 7 | 0.0001 |
| 9 | Glinide [EPC] | 1 | 0.0001 |